Evidence map›Paper›PMID 35169155›Full record

ArticleNPJ Parkinson's disease2022

Author Correction: Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson's disease.

Tommaso Bocci, Marco Prenassi, Mattia Arlotti, Filippo Maria Cogiamanian, Linda Borellini, Elena Moro, Andres M Lozano, Jens Volkmann, Sergio Barbieri, Alberto Priori and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in NPJ Parkinson's disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Tommaso Bocci *"Aldo Ravelli" Research Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan Medical School, Milan, Italy.
Marco Prenassi *Dipartimento in Ingegneria e Architettura, Università degli studi di Trieste, Trieste, Italy.ORCID http://orcid.org/0000-0003-0240-0860
Mattia ArlottiNewronika S.p.A., Milan, Italy.
Filippo Maria CogiamanianU.O. Fisiopatologia,Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
Linda BorelliniU.O. Fisiopatologia,Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
Elena MoroDivision of Neurology, Centre Hospitalier Universitaire de Grenoble, Grenoble, France.
Andres M LozanoDivision of Neurosurgery, University of Toronto, Toronto, ON, Canada.
Jens VolkmannDepartment of Neurology, University of Wurzburg, Würzburg, Germany.
Sergio BarbieriU.O. Fisiopatologia,Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
Alberto Priori"Aldo Ravelli" Research Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan Medical School, Milan, Italy. Alberto.priori@unimi.it.ORCID http://orcid.org/0000-0002-1549-3851
Sara MarcegliaDipartimento in Ingegneria e Architettura, Università degli studi di Trieste, Trieste, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35169155
PMCPMC8847510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.